Skip to main content
SpringerLink
Log in

Controverse

Debate

  • Published:
Côlon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Peyrin-Biroulet L, Bonnaud G, Bourreille A, et al (2013) Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED). Endoscopy 45: 936–43

    Article  PubMed  Google Scholar 

  2. Beaugerie L, Itzkowitz SH (2015) Cancers complicating inflammatory bowel disease. N Engl J Med 372: 1441–52

    Article  CAS  PubMed  Google Scholar 

  3. Vienne A, Simon T, Cosnes J, et al (2011) Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther 34: 188–95

    Article  CAS  PubMed  Google Scholar 

  4. Bessissow T, Bisschops R (2013) Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis. Expert Rev Gastroenterol Hepatol 7: 57–67

    Article  CAS  PubMed  Google Scholar 

  5. Van Assche G, Dignass A, Bokemeyer B, et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7: 1–33

    Article  PubMed  Google Scholar 

  6. Hurlstone DP, Kiesslich R, Thomson M, et al (2008) Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis. Gut 57: 196–204 (Retraction in: Gut 2008;57:1634)

    Article  CAS  PubMed  Google Scholar 

  7. Moussata D, Allez M, Cazals-Hatem D, et al (2017) Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut [in press]

    Google Scholar 

  8. Laine L, Kaltenbach T, Barkun A, et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 148: 639–51

    Article  PubMed  Google Scholar 

  9. Toruner M, Harewood GC, Loftus EV Jr, et al (2005) Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 11: 428–34

    Article  PubMed  Google Scholar 

Références

  1. Reimund JM (2005) Dépistage des dysplasies et cancers coliques dans les MICI. FMCHGE. POST’U

    Google Scholar 

  2. Beaugerie L, Itzkowitz SH (2015) Cancers complicating inflammatory bowel disease. N Engl J Med 373:195

    CAS  PubMed  Google Scholar 

  3. Munkholm P (2003) Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 18: 1–5

    Article  PubMed  Google Scholar 

  4. Lashner BA, Kane SV, Hanauer SB (1990) Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85: 1083–7

    CAS  PubMed  Google Scholar 

  5. Soetikno R, Sanduleanu S, Kaltenbach T (2014) An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am 24: 483–520

    Article  PubMed  Google Scholar 

  6. Hassan C, Bretthauer M, Kaminski MF, et al (2013) Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 45: 142–50

    Article  CAS  PubMed  Google Scholar 

  7. Toruner M, Harewood GC, Loftus EV, et al (2005) Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 11: 428–34

    Article  PubMed  Google Scholar 

  8. Rubin DT, Rothe JA, Hetzel JT, et al (2007) Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 65: 998–1004

    Article  PubMed  Google Scholar 

  9. Rutter MD, Saunders BP, Wilkinson KH, et al (2004) Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 6: 334–9

    Article  Google Scholar 

  10. Subramanian V, Ramappa V, Telakis E, et al (2013) Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 19: 350–5

    Article  PubMed  Google Scholar 

  11. Van Assche G, Dignass A, Bokemeyer B, et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7: 1–33

    Article  PubMed  Google Scholar 

  12. Vuitton L, Gonzalez F, Koch S (2013) Surveillance endoscopique de la dysplasie dans les maladies inflammatoires chroniques de l’intestin. Acta Endoscopica 43: 207–13

    Article  Google Scholar 

  13. Laine L, Kaltenbach T, Barkun A, et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81: 489–501

    Article  PubMed  Google Scholar 

  14. Gumaste V, Sachar B, Greenstein AJ (1992) Benign and malignant colorectal strictures in ulcerative colitis. Gut 33: 938–41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Noor M, Prashant K, Faisal A (2015) High definition white light endoscopy versus high definition with chromoendoscopy in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Poster 1421. 23rd United European Gastroenterology Week, Barcelona, Spain, 24–28 October

    Google Scholar 

  16. Heresbach D, Napoléon B, Delchier JC (2009) Indications des biopsies digestives au cours de la fibroscopie ou du dépistage des néoplasies oesogastroduodénales. Acta Endoscopica 39: 274–7

    Google Scholar 

  17. Vienne A, Simon T, Cosnes J, et al (2011) Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther 34: 188–95

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépatogastroentérologie, hôpital Haut-Lévêque, CHU de Bordeaux, F-33604, Pessac, France

    D. Laharie

  2. Endoscopie digestive, Sorbonne Universités et AP–HP, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, F-75012, Paris, France

    X. Dray

Authors
  1. D. Laharie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Dray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to D. Laharie or X. Dray.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laharie, D., Dray, X. Controverse. Colon Rectum 11, 108–116 (2017). https://doi.org/10.1007/s11725-017-0704-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11725-017-0704-4

Search

Navigation